These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 9688051

  • 1. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.
    Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P.
    Pharm Res; 1998 Jul; 15(7):1001-6. PubMed ID: 9688051
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L, Murphy GF, Béliveau R.
    Int J Cancer; 1998 May 29; 76(5):729-37. PubMed ID: 9610733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats.
    Hanafy A, Langguth P, Spahn-Langguth H.
    Eur J Pharm Sci; 2001 Feb 29; 12(4):405-15. PubMed ID: 11231107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C, Garrigos M, Orlowski S.
    Biochem J; 1998 Jul 15; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [Abstract] [Full Text] [Related]

  • 9. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T, Kamiya M, Ozawa M, Fujita T, Yamamoto A, Yamashita S, Ohnishi S, Isomura Y.
    Drug Metab Pharmacokinet; 2006 Jun 15; 21(3):238-44. PubMed ID: 16858128
    [Abstract] [Full Text] [Related]

  • 10. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y, Kawasaki M, Sakane T, Omatsu H, Moriya Y, Nakamura T, Sakaeda T, Okumura K, Langguth P, Yamashita S.
    Drug Metab Pharmacokinet; 2006 Oct 15; 21(5):414-23. PubMed ID: 17072095
    [Abstract] [Full Text] [Related]

  • 11. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
    Parasrampuria DA, Lantz MV, Benet LZ.
    Pharm Res; 2001 Jan 15; 18(1):39-44. PubMed ID: 11336351
    [Abstract] [Full Text] [Related]

  • 12. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P.
    J Pharm Sci; 1999 Oct 15; 88(10):1067-72. PubMed ID: 10514357
    [Abstract] [Full Text] [Related]

  • 13. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
    Pajeva IK, Wiese M.
    J Med Chem; 2002 Dec 19; 45(26):5671-86. PubMed ID: 12477351
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
    Nakayama A, Saitoh H, Oda M, Takada M, Aungst BJ.
    Eur J Pharm Sci; 2000 Oct 19; 11(4):317-24. PubMed ID: 11033075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein.
    Horton JK, Thimmaiah KN, Altenberg GA, Castro AF, Germain GS, Gowda GK, Houghton PJ.
    Mol Pharmacol; 1997 Dec 19; 52(6):948-57. PubMed ID: 9415704
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.
    Declèves X, Chappey O, Boval B, Niel E, Scherrmann JM.
    Pharm Res; 1998 May 19; 15(5):712-8. PubMed ID: 9619779
    [Abstract] [Full Text] [Related]

  • 20. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
    Martin C, Higgins CF, Callaghan R.
    Biochemistry; 2001 Dec 25; 40(51):15733-42. PubMed ID: 11747450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.